OCULIS HOLDING AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.07 USD | +0.88% |
|
-5.70% | +7.48% |
| May. 08 | Oculis Holding AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | H.C. Wainwright Adjusts Price Target on Oculis Holding to $28 From $29, Keeps Buy Rating | MT |
Chart calendar Oculis Holding AG
4933c60c306d7b5a26c8287ac.uM1ucOluUaaoW_tJuH_uusKGWDqdT3aaB-SRt285e0o.laUHILtYHfLKOIgk3km2i_foEQ_ZDRH3faf3gwdAEQf9rwhF2l0-08Q4nA~ca2b422dbec127826c7f01c1f0acc150
Upcoming events on Oculis Holding AG
Past events on Oculis Holding AG
| 2024-05-08 | Retina World Congress |
| 2024-05-08 04:10 pm | Q1 2024 Earnings Release |
| 2024-04-15 | Van Lanschot Kempen Life Sciences Conference |
| 2024-04-11 08:00 am | Needham Healthcare Conference |
| 2024-04-06 | American Society of Cataract and Refractive Surgery Meeting |
| 2024-03-18 06:30 am | Q4 2023 Earnings Release |
| 2024-03-13 10:40 am | Leerink Partners Global Biopharma Conference |
| 2024-02-28 09:00 am | R&D Day |
| 2024-02-08 05:40 am | BioCapital Europe Conference |
| 2024-02-07 09:30 am | Stifel Biotech Executive Summit |
| 2024-02-01 05:30 pm | Next Generation Ophthalmic Drug Delivery Summit |
| 2023-11-27 | Piper Sandler Healthcare Conference |
| 2023-11-27 09:00 am | BTIG Ophthalmology Day |
| 2023-11-15 09:45 am | Stifel Healthcare Conference |
| 2023-10-06 06:15 am | Euretina Conference |
| 2023-09-14 08:10 am | Pareto Securities HC Conference |
| 2023-09-11 08:30 am | H.C. Wainwright Global Investment Conference |
| 2023-09-06 | Ophthalmology Futures European Forum |
| 2023-08-30 08:00 am | Swiss Ophthalmological Society Congress |
| 2023-08-29 06:30 am | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 0,00 | 0,88 0,78 12.87% | 0,91 |
|
EBITDA Million CHF | Released Forecast Spread | 0,00 | 0,00 -60,3 - | -55,1 |
|
EBIT Million CHF | Released Forecast Spread | 0,00 | -80,7 -75,0 -7.67% | -56,2 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 0,00 | -88,7 -87,3 -1.57% | -71,5 |
|
Net income Million CHF | Released Forecast Spread | -38,7 | -88,8 -83,8 -5.92% | -58,1 |
|
EPS CHF | Released Forecast Spread | -12,9 | -2,97 -2,92 -1.59% | -1,55 |
| Announcement Date | 28/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 0,19 | 0,25 0,19 31.75% | 0,22 0,17 30.23% | 0,19 0,21 -11.49% | 0,22 0,26 -13.88% | 0,24 | 0,24 | 0,21 | ||
|
EBITDA Million CHF | Released Forecast Spread | -9,39 | -10,4 | -12,9 -9,18 -40.33% | -12,7 | ||||||
|
EBIT Million CHF | Released Forecast Spread | -9,57 | -10,7 -10,2 -5.77% | -13,0 -10,7 -21.57% | -12,2 -13,4 9.26% | -15,3 -13,8 -10.77% | -14,4 | -14,8 | -15,8 | ||
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -11,1 | -12,8 -11,9 -7.48% | -17,5 -11,7 -49.93% | -12,5 -13,7 8.67% | -16,1 -14,2 -13.13% | -16,7 | -18,4 | -20,3 | ||
|
Net income Million CHF | Released Forecast Spread | -9,78 | -12,9 -10,1 -26.87% | -17,4 -11,3 -53.72% | -12,5 -14,6 14.18% | -16,1 -13,6 -18.44% | -14,0 | -14,8 | -15,6 | ||
|
EPS CHF | Released Forecast Spread | -0,30 | -0,38 -0,29 -28.91% | -2,53 -0,51 -396.08% | -0,48 -0,33 -46.75% | -0,34 -0,40 15.11% | -0,48 | -0,44 -0,37 -18.28% | -0,38 | -0,39 | -0,40 |
| Announcement Date | - | 29/08/23 | 29/08/23 | 15/11/23 | 18/03/24 | - | 08/05/24 | - | - | - |
More events
Past sector events for Oculis Holding AG
| 2024-05-10 07:00 am | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 04:10 pm | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | OMNIAB, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OCS Stock
- Calendar Oculis Holding AG